{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:03Z","timestamp":1792090023715,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.urology.2014.02.006","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T15:45:10Z","timestamp":1397403910000},"page":"1316-1321","source":"Crossref","is-referenced-by-count":19,"title":["Weight Gain on Androgen Deprivation Therapy: Which Patients Are at Highest Risk?"],"prefix":"10.1016","volume":"83","author":[{"given":"Daniel M.","family":"Seible","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-6195","authenticated-orcid":false,"given":"Andrew S.","family":"Hyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair J.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Mitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.02.006_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.02.006_bib2","series-title":"SEER: Surveillance, Epidemiology and End Results (SEER)","year":"2013"},{"key":"10.1016\/j.urology.2014.02.006_bib3","first-page":"1998","article-title":"Metabolic complications of androgen deprivation therapy for prostate cancer","volume":"181","author":"Saylor","year":"2009","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.006_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2014.02.006_bib5","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2014.02.006_bib6","first-page":"100","article-title":"Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia","volume":"154","author":"Eri","year":"1995","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.006_bib7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.02.006_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11764-009-0114-1","article-title":"The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis","volume":"4","author":"Haseen","year":"2010","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.urology.2014.02.006_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1464-410X.2010.09679.x","article-title":"A\u00a0natural history of weight change in men with prostate cancer on androgen deprivation therapy: results from the SEARCH database","volume":"107","author":"Kim","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.02.006_bib10","first-page":"2183","article-title":"Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer","volume":"188","author":"Timilshina","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.02.006_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00520-011-1169-x","article-title":"Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer","volume":"20","author":"Alberga","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.urology.2014.02.006_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.pcan.4500975","article-title":"Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer","volume":"10","author":"Galv\u00e3o","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2014.02.006_bib13","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"American Diabetes Association: Diagnosis and classification of diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urology.2014.02.006_bib14","first-page":"499","article-title":"Age differences in serum androgen levels in normal adult males","volume":"53","author":"Purifoy","year":"1981","journal-title":"Hum Biol"},{"key":"10.1016\/j.urology.2014.02.006_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2014.02.006_bib16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2014.02.006_bib17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.02.006_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: a new category of obesity in the elderly","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.urology.2014.02.006_bib19","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/cncr.23440","article-title":"Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome","volume":"112","author":"Smith","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.02.006_bib20","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2011.38.8850","article-title":"Sarcopenia during androgen-deprivation therapy for prostate cancer","volume":"30","author":"Smith","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2014.02.006_bib21","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2014.02.006_bib22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.02.006_bib23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/cncr.21381","article-title":"Changes in bone mineral density and body composition during initial and long-term gonadotropin releasing hormone agonist treatment for prostate carcinoma","volume":"104","author":"Lee","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2014.02.006_bib24","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2014.02.006_bib25","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance exercise in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.urology.2014.02.006_bib26","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.02.006_bib27","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.02.006_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2011.04.067","article-title":"Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction","volume":"82","author":"Nguyen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:08:18Z","timestamp":1648825698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429514001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090429514001253"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.02.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}